Enhanced osseointegration of three-dimensional supramolecular bioactive interface through osteoporotic microenvironment regulation

Haotian Bai,Yue Zhao,Chenyu Wang,Zhonghan Wang,Jincheng Wang,Hou Liu,Yubin Feng,Quan Lin,Zuhao Li,He Liu
DOI: https://doi.org/10.7150/thno.43736
IF: 11.6
2020-01-01
Theranostics
Abstract:Purpose: Osteoporosis is more likely to cause serious complications after joint replacement, mainly due to physiological defects of endogenous osteogenic cells and the pathological osteoclast activity. It is a feasible solution to design a prosthetic surface interface that specifically addresses this troublesome situation.Methods: A novel "three-dimensional (3D) inorganic-organic supramolecular bioactive interface" was constructed consisting of stiff 3D printing porous metal scaffold and soft multifunctional, self-healable, injectable, and biodegradable supramolecular polysaccharide hydrogel. Apart from mimicking the bone extracellular matrix, the bioactive interface could also encapsulate bioactive substances, namely bone marrow mesenchymal stem cells (BMSCs) and bone morphogenetic protein-2 (BMP-2). A series of in vitro characterizations, such as topography and mechanical characterization, in vitro release of BMP-2, biocompatibility analysis, and osteogenic induction of BMSCs were carried out. After that, the in vivo osseointegration effect of the bioactive interface was investigated in detail using an osteoporotic model.Results: The administration of injectable supramolecular hydrogel into the inner pores of 3D printing porous metal scaffold could obviously change the morphology of BMSCs and facilitate its cell proliferation. Meanwhile, BMP-2 was capable of being sustained released from supramolecular hydrogel, and subsequently induced osteogenic differentiation of BMSCs and promoted the integration of the metal microspores-bone interface in vitro and in vivo. Moreover, the osteoporosis condition of bone around the bioactive interface was significantly ameliorated.Conclusion: This study demonstrates that the 3D inorganic-organic supramolecular bioactive interface can serve as a novel artificial prosthesis interface for various osteogenesis-deficient patients, such as osteoporosis and rheumatoid arthritis.
medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is that in joint replacement surgery, osteoporotic patients have insufficient number of bone marrow mesenchymal stem cells (BMSCs) and low osteogenic activity, resulting in poor integration between the implant and bone tissue, and then causing a series of complications, such as prosthesis interface displacement, loosening and even surrounding fractures. To meet this challenge, the study designed a new three - dimensional inorganic - organic supramolecular bioactive interface, aiming to enhance the integration of the implant and bone tissue by regulating the osteoporotic microenvironment. Specifically, the study constructed a new "three - dimensional inorganic - organic supramolecular bioactive interface" composed of a 3D - printed porous metal scaffold and a soft multi - functional self - healing, injectable and degradable supramolecular polysaccharide hydrogel. This bioactive interface not only mimics the bone extracellular matrix, but also can encapsulate bioactive substances, such as bone marrow mesenchymal stem cells (BMSCs) and bone morphogenetic protein - 2 (BMP - 2). The study verified the performance of this bioactive interface through a series of in vitro experiments, such as morphological and mechanical characterization, in vitro release of BMP - 2, biocompatibility analysis and osteogenic induction of BMSCs. Subsequently, the osteointegration effect of this bioactive interface in vivo was studied in detail using an osteoporosis model. The research results show that injecting the injectable supramolecular hydrogel into the internal pores of the 3D - printed porous metal scaffold can significantly change the morphology of BMSCs and promote their cell proliferation. At the same time, BMP - 2 can be continuously released from the supramolecular hydrogel, thereby inducing the osteogenic differentiation of BMSCs and promoting the integration of the metal micropore - bone interface. In addition, the osteoporosis condition around this bioactive interface has also been significantly improved. In conclusion, this study shows that this three - dimensional inorganic - organic supramolecular bioactive interface can be used as a new artificial prosthesis interface, which is suitable for various patients with insufficient osteogenic ability, such as osteoporotic and rheumatoid arthritis patients.